Glucagon-like peptide 1 receptor agonist prescription linked to reduction in risk for suicidal ideation or attempts ...

The company has committed £279 million ($364 million) to support national efforts aimed at reducing obesity, a critical ...

Fat Joe opens up about his impressive 200-pound weight loss, revealing whether Ozempic played a role in his transformative ...

Chinese insulin maker Gan & Lee Pharmaceuticals is wading into the obesity world with an injectable GLP-1 agonist that beat Novo Nordisk's Ozempic (semaglutide) at lowering glycated hemoglobin (HbA1c) ...

Hoping your company will begin paying for anti-obesity medications like Wegovy? You may be in luck. A growing number of ...

GLP-1 agonists work by triggering the pancreas to produce more insulin, which reduces blood sugar levels in those with type 2 ...

Half of people who develop blood poisoning, otherwise known as sepsis, are dead within a couple of years, a new study finds.

Today's health news includes how the U.S. primary care crisis is hurting the fight against heart disease, the Nobel gender ...

GLP-1 agonists work by suppressing patients’ appetites and have been approved to treat obesity and type 2 diabetes in the ...

The U.K. is exploring whether obesity drugs could be used to curb joblessness after signing a major investment deal with ...

It comes after Health Secretary Wes Streeting suggested that weight-loss jabs could be given to unemployed people to help ...